Free access to world-class biological databases for European science thanks to FELICS

May 03, 2006

Today the European Molecular Biology Laboratory's (EMBL) European Bioinformatics Institute (EBI), the Swiss Institute for Bioinformatics (SIB), the University of Cologne, Germany, and the European Patent Office launch FELICS (Free European Life-science Information and Computational Services). The new project coordinated by the EBI will give researchers unrestricted access to some of the world's most important biological databases. The Commission of the European Union has awarded 16.7 million Euro under the Research Infrastructures action of the sixth Framework Programme (FP6) for the project to develop, enhance and interlink many of the most important data resources in Europe and widen their accessibility to the scientific community worldwide. This is the largest ever European award for computational infrastructures needed to support biological research.

The EBI is Europe's largest curator and disseminator of biological information, and has played a leading role in ensuring that information from genomes, for example, is provided to scientists and the public. Its predecessor, the EMBL Data Library, launched the world's first universal public database of DNA sequences in the early 1980s. FELICS encompasses many of the EBI's familiar databases, but will also feature some crucial new activities. Support for BRENDA, the University of Cologne's enzyme database, will release it from its current licensing constraints and provide unrestricted access to its data. FELICS will also offer specific support for the extraction of information from patent literature in collaboration with the European Patent Office, who will also collaborate closely on CheBI, a database of chemical entities of biological interest, which will receive a substantial boost as part of the project.

"Bioinformatics now pervades biology," says Graham Cameron, Associate Director of the EBI and coordinator of FELICS. "Bioinformatics experts no longer sit between biologist and database. Researchers expect to directly access the databases and do real work. FELICS gives scientists the electronic right to roam the biological knowledge space. User-friendly software, developed within FELICS and other Commission-funded projects, will facilitate navigation of that space."

Biomolecular databases are a crucial scientific infrastructure. The EBI site currently receives around 2 million hits every day, and even the most conservative estimates suggest a rise to ten million during the next five years. The need for centralized public information resources to provide global services for basic and applied biomolecular and biomedical research can only increase.

"With other support from the EU and the EMBL Member States, the EBI coordinates several FP6 networks of excellence between leading European institutes in bioinformatics and is involved in many others. These connections will ensure that the benefits of FELICS spread far beyond the four partners involved in the project," Cameron says.

European Molecular Biology Laboratory

Related Bioinformatics Articles from Brightsurf:

Glyphosate may affect human gut microbiota
More than half of bacterial species in the core of the human gut microbiome are potentially sensitive to glyphosate, shows new research.

Next-gen bioinformatics tool enables big data analysis without programming expertise
A new data analysis tool developed by MD Anderson researchers incorporates a user-friendly, natural-language interface to aid biomedical researchers without bioinformatics or programming expertise to conduct intuitive data.

Embracing bioinformatics in gene banks
Scientists from the IPK have explored, within a perspective paper, the upcoming challenges and possibilities of the future of gene banks.

New bioinformatics tool identifies and classifies CRISPR-Cas systems
Designed to improve the utility and availability of increasingly diverse CRISPR-Cas genome editing systems, the new CRISPRdisco automated pipeline helps researchers identify CRISPR repeats and cas genes in genome assemblies.

AMP Iissues consensus guideline recommendations for NGS bioinformatics pipelines
The Association for Molecular Pathology, the premier global, non-profit molecular diagnostics professional society, today published 17 consensus recommendations to help clinical laboratory professionals achieve high-quality sequencing results and deliver better patient care.

Advances: Bioinformatics applied to development & evaluation of boron-containing compounds
The interest for developing boron-containing compounds as drugs is increasing after some successful cases.

When life sciences become data sciences
The University of Freiburg offers Europe-wide infrastructure and service in Bioinformatics.

Bioinformatics brings to light new combinations of drugs to fight breast cancer
A bioinformatics analysis of pairing 64 drugs used to treat breast cancer allows researchers at IRB Barcelona to identify 10 previously untested combinations with potential to tackle resistance to breast cancer treatment.

New bioinformatics tool tests methods for finding mutant genes that 'drive' cancer
Computational scientists and cancer experts have devised bioinformatics software to evaluate how well current strategies distinguish cancer-promoting mutations from benign mutations in cancer cells.

EDGE bioinformatics brings genomics to everyone
A new bioinformatics platform called Empowering the Development of Genomics Expertise (EDGE) will help democratize the genomics revolution by allowing users with limited bioinformatics expertise to quickly analyze and interpret genomic sequence data.

Read More: Bioinformatics News and Bioinformatics Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to